201 results
Page 4 of 11
424B5
yin8bicrlro5k3
25 Jun 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-1.1
qrvi f6dg9ye
25 Jun 21
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-10.1
c9qp0ysu6j6k6 ko
25 Jun 21
Entry into a Material Definitive Agreement
5:22pm
8-K
qghbz194buzous
28 May 21
Submission of Matters to a Vote of Security Holders
4:34pm
8-K
EX-99.1
xx3sx
24 Mar 21
Moleculin Biotech, Inc. Reports Financial Results
7:31am
8-K
EX-99.1
gjhthxvuc9ms6 60glmj
8 Feb 21
Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases
7:29am
8-K
EX-1.1
xpkru1rgh4ze6hhhvxk
4 Feb 21
Moleculin Announces Proposed Underwritten Public Offering
4:07pm
424B5
3f9bcg85
4 Feb 21
Prospectus supplement for primary offering
4:01pm
S-3MEF
EX-23.1
ft2 6kyhxpmis7
2 Feb 21
Registration of additional securities for an S-3
9:45pm
S-3MEF
EX-5
bmhf6z n5g8rkd
2 Feb 21
Registration of additional securities for an S-3
9:45pm